Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.34% Nasdaq Up0.16%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM

7.09 May 21, 4:00PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.8
Mean Recommendation (last week):1.8
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:8.75
Median Target:8.50
High Target:11.00
Low Target:7.00
No. of Brokers:4

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 9, 2010HapoalimInitiated Outperform
Dec 8, 2009Jefferies & CoInitiated Buy
Jul 28, 2008JP MorganDowngradeOverweightNeutral
Jul 28, 2008Banc of America SecDowngradeBuyNeutral
Jul 27, 2008Caris & CompanyDowngradeBuyAbove Average
May 1, 2008Caris & CompanyInitiated Buy
Sep 9, 2007Banc of America SecInitiated Buy
May 7, 2007CitigroupInitiated Hold
Feb 13, 2007Friedman BillingsInitiated Outperform
May 22, 2006Banc of America SecInitiated Buy

More Upgrades & Downgrades for VNDA

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1111
Buy3332
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.